Roberta Murru

9PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2026
Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study.

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Mar 28, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Stefano Molica, Potito Rosario Scalzulli, Lydia Scarfò

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

|Oct 16, 2024
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population.

Silvana A M Urru, Flavia Mayer, Stefania Spila Alegiani

|Jun 19, 2024
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents.

Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro

Pageof 2

Frequent Collaborators

4 joint publications

Marzia Varettoni

4 joint publications

Francesca Romana Mauro

4 joint publications

Marta Coscia

3 joint publications

Andrea Galitzia